IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Center for VulvoVaginal Disorders, Washington D.C., District of Columbia

Centers for Vulvovaginal Disorders, NY, New York, New York